|
CCNL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63957736276643E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.32319949336579E-10 |
| Normal-vs-Stage2 |
8.07431899119138E-12 |
| Normal-vs-Stage3 |
1.27979959962943E-10 |
| Normal-vs-Stage4 |
4.40979999960511E-07 |
| Stage1-vs-Stage2 |
1.301970E-03 |
| Stage1-vs-Stage3 |
2.714200E-02 |
| Stage1-vs-Stage4 |
5.147400E-01 |
| Stage2-vs-Stage3 |
1.959780E-01 |
| Stage2-vs-Stage4 |
1.086840E-01 |
| Stage3-vs-Stage4 |
4.802600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.33669775037993E-11 |
| Normal-vs-AfricanAmerican |
1.781870E-04 |
| Normal-vs-Asian |
4.36220000010756E-07 |
| Caucasian-vs-AfricanAmerican |
7.457600E-01 |
| Caucasian-vs-Asian |
4.526600E-01 |
| AfricanAmerican-vs-Asian |
9.207800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76909997551667E-09 |
| Normal-vs-Female |
1.79534165312134E-12 |
| Male-vs-Female |
8.672600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97220000330844E-08 |
| Normal-vs-Age(41-60Yrs) |
1.04459996208561E-09 |
| Normal-vs-Age(61-80Yrs) |
1.8484003216912E-10 |
| Normal-vs-Age(81-100Yrs) |
9.921100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.691200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.277400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.200800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.136000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.789600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.91754999999683E-05 |
| Classical-VS-Follicular |
2.948600E-01 |
| Classical-VS-Other |
6.113000E-01 |
| Classical-VS-Normal |
2.31950000317838E-08 |
| Tall-VS-Follicular |
1.369550E-01 |
| Tall-VS-Other |
1.066840E-01 |
| Tall-VS-Normal |
2.01905159258331E-12 |
| Follicular-VS-Other |
5.507400E-01 |
| Follicular-VS-Normal |
6.11120000049148E-07 |
| Other-VS-Normal |
4.458400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.82149875580262E-11 |
| Normal-vs-N1 |
2.963400E-04 |
| N0-vs-N1 |
2.148500E-02 |
|
|
